Estrogen receptor negative and progesterone receptor positive primary breast cancer: Pathological characteristics and clinical outcome

By Bernoux A.   de Cremoux P.   Lainé-Bidron C.   Martin E.C.   Asselain B.   Magdelénat H.  

Breast Cancer Research and Treatment, Vol. 49, Iss. 3, 1998-06 ,pp. : 219-225

Springer Publishing Company

Access to resources Recommend Favorite

A model of spontaneous mouse mammary tumor for human estrogen receptor- and progesterone receptor-negative breast cancer

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2241-2249

Spandidos Publications

Access to resources Recommend Favorite

Shift in cytotoxic target from estrogen receptor-positive to estrogen receptor-negative breast cancer cells by trastuzumab in combination with taxane-based chemotherapy

By              

Oncology Letters, Vol. 2, Iss. 2, 2011-01 ,pp. : 303-308

Spandidos Publications

Access to resources Recommend Favorite

Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer

By Hosoda Mitsuchika   Yamamoto Mitsugu   Nakano Kiichiroh   Hatanaka Kanako   Takakuwa Emi   Hatanaka Yutaka   Matsuno Yoshihiro   Yamashita Hiroko  

Breast Cancer Research and Treatment, Vol. 144, Iss. 2, 2014-04 ,pp. : 249-261

Springer Publishing Company

Access to resources Recommend Favorite

S-phase fraction combined with other patient and tumor characteristics for the prognosis of node-negative, estrogen- receptor-positive breast cancer

By Bryant J.   Fisher B.   Gündüz N.   Costantino J.P.   Emir B.  

Breast Cancer Research and Treatment, Vol. 51, Iss. 3, 1998-10 ,pp. : 239-253

Springer Publishing Company

Access to resources Recommend Favorite